Institute for Clinical & Economic Review to Assess Treatments for Multiple Sclerosis
April 22, 2022
April 22, 2022
BOSTON, Massachusetts, April 22 (TNSRes) -- The Institute for Clinical and Economic Review issued the following news release:
* * *
Report will be subject of New England CEPAC meeting in January 2023; Draft Scoping Document open to public comment until May 12, 2022
* * *
The Institute for Clinical and Economic Review (ICER) announced today that it will assess the comparative clinical effectiveness and value of treatments for multiple sclerosis: . . .
* * *
Report will be subject of New England CEPAC meeting in January 2023; Draft Scoping Document open to public comment until May 12, 2022
* * *
The Institute for Clinical and Economic Review (ICER) announced today that it will assess the comparative clinical effectiveness and value of treatments for multiple sclerosis: . . .